Doccla funding news – London-based Doccla Secures £35Million in Series B Round Funding

Doccla, a London-based company, will be able to strengthen its position in the UK and Ireland thanks to the financing. In addition to working with NHS Trusts in more than half of the NHS regions, it monitors patients in more than ten European nations. It also recently partnered with Ireland's HSE.

With this new capital, itwill be able to grow throughout Europe, with a focus on France and the DACH region. It will also be positioned for future growth in other foreign markets outside of Europe.

Read also - BrowserStack Acquisition News – BrowserStack Acquires Bird Eats Bug, Launches Bug Capture to Accelerate Its Test Platform Vision

Like any hospital or general practitioner office in England, it is overseen by the Care Quality Commission and serves patients from almost all of the NHS regions. With the help of the technology, 40 pathways are monitored around-the-clock. Medical professionals may view patient data instantly and highlight alarming signals ahead of time to schedule in-person appointments before problems get worse. In addition to lowering emergency admission rates, this preventive strategy also lessens anxiety for patients and their families.

Doccla Founder Martin Ratz commented: “Doccla was founded to provide hospital-level care and support at home for multiple patient profiles across the acuity spectrum: enabling the early discharge of patients, as well as ensuring that for those with chronic care needs, hospital admission might be avoided in the first place. Technology-enabled virtual wards deliver great benefits for patients, who can recover at home, while freeing up resources for healthcare providers. Our work has proven immensely valuable to the UK’s National Health Service and we’re excited to scale our European operations. At the same time, we see exceptional upside potential for our services in the Life Sciences sector, and will continue to invest in our data science operations.”

Lakestar Partner and new Doccla board member Oliver Heimes added: “In less than five years Doccla has gone from a research project to establishing itself as the market leader in the UK. We are confident they will not just maintain that position but successfully launch in new markets, whilst diversifying their services. Remote patient care delivers proven results and is ushering in new standards in the healthcare systems globally.”

About Doccla

Martin Ratz had an unplanned heart attack, which led to the founding of Doccla. Martin discovered during his medical journey that there was a gap in the care that patients received after being admitted to the hospital. He co-founded Doccla with Dag Larsson, the company's CEO, and has experience in the healthtech industry.